Back
Design Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
47
DSGN
Design Therapeutics
Last Price:
5.88
Seasonality Move:
-19.8%
Sell
43
NBY
NovaBay Pharmaceuticals
Last Price:
0.72
Seasonality Move:
-18.64%
Sell
47
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy, Sell or Hold?
- The current Design Therapeutics [DSGN] share price is $5.88. The Score for DSGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- DSGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.74. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSGN Stock Price Chart
What is Design Therapeutics's stock price today?
-
The Design Therapeutics share price today is $5.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.74
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
DSGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 63.14 | Buy |
Chaikin Money Flow: | -157563 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.7 - 5.58) | Buy |
Bollinger Bands (100): | (3.68 - 5.02) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 61.79 | Buy |
Chaikin Money Flow: | -53331864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.45 - 0.57) | Buy |
Bollinger Bands (100): | (0.56 - 3.36) | Sell |
DSGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.66 | Buy |
20-day SMA: | 5.2 | Buy |
50-day SMA: | 4.82 | Buy |
200-day SMA: | 3.62 | Buy |
8-day EMA: | 5.64 | Buy |
20-day EMA: | 5.3 | Buy |
50-day EMA: | 4.85 | Buy |
200-day EMA: | 4.23 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.52 | Buy |
20-day SMA: | 0.5 | Buy |
50-day SMA: | 0.83 | Sell |
200-day SMA: | 3.74 | Sell |
8-day EMA: | 0.55 | Buy |
20-day EMA: | 0.55 | Buy |
50-day EMA: | 0.94 | Sell |
200-day EMA: | 8.27 | Sell |
Design Therapeutics Earnings Growth & DSGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Design Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |